Neurocysticercocis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Neurocysticercocis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Transparency Market Research
  • Ongoing
  • Therapeutic Area

Report Description


Global NCC Therapeutics Market: Overview

Neurocysticercosis (NCC Therapeutics) is a significant yet under-recognized health concern across the world. NCC is caused by Taenia solium, a pork tapeworm which is found in the small intestine of humans. The larvae of Taenia solium develop into the adults, upon ingestion of undercooked vegetables or pork meat. The adult Taenia solium enters the nervous system and causes epilepsy or other neurological disorders. Globally, two to three million people are estimated to suffer from epilepsy caused by NCC. NCC is primarily diagnosed by CT scan, MRI, and serological tests. In particular, CT scan of the brain is found to be effective in diagnosing NCC in humans. Several physicians consider surgical intervention as a superior treatment over medications.

The global NCC therapeutics market is driven by rising incidence of NCC therapeutics, high diagnosis and treatment rates of NCC therapeutics, and favorable health care reimbursement scenario. Low awareness about NCC therapeutics is considered a potential restraint for the global NCC therapeutics market. Sometimes, low specificity and sensitivity of diagnostic procedures (for example, CT scan and MRI) can display no symptoms of NCC therapeutics or represent false cases. This poses a key challenge for physicians in terms of administration of medicines for NCC therapeutics. On the other hand, several revolutionary technologies introduced in diagnostic methods and innovation of novel drugs are likely to open new growth avenues for the global NCC therapeutics market in the near future.

Global NCC Therapeutics Market: Key Segments

Based on NCC therapeutics type, the global NCC therapeutics market can be classified into intra-parenchymal NCC and extra-parenchymal NCC therapeutics. Intra-parenchymal is most commonly seen among children aged over five years, but it can occur in toddlers or infants also. Based on drug type, the NCC therapeutics market has been categorized into anti-helmintics, anti-epileptics, corticosteroids, and others. In terms of route of administration, the market has been divided into oral and parenteral. In terms of distribution channel, the global NCC therapeutics market has been segmented into hospital pharmacies, retail pharmacies & drug stores, and others.

Geographically, the global NCC therapeutics market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to the Centers for Disease Prevention & Control (CDC), nearly 1,500 new NCC patients are admitted to hospitals in the U.S. every year. This infection is predominantly observed among immigrants. According to a study published in the journal Pathogens and Global Health, nearly 0.5 per 100,000 people suffer from NCC in the U.S. every year. On the other hand, approximately 1.5–5.8 cases of NCC per 100,000 Hispanic population are found in the U.S. every year. The infection rate of NCC in Europe is variable. Western Europe witnesses high infection rate as compared to other countries in Europe. Among western parts of Europe, more than 15 per 100,000 people are infected by NCC in France, Germany, and Belgium every year. Significant infection rate, high diagnosis and treatment rates of NCC, developed health care infrastructure, and availability of medical reimbursements are likely to drive the NCC therapeutics market in North America and Europe during the forecast period. In Asia Pacific, around 25–30 cases per 100,000 population suffer from NCC every year. Large patient pool, rising incidence of NCC, and developing health care infrastructure are estimated to drive the NCC market in Asia Pacific at a noteworthy rate during the forecast period. Low awareness about NCC and low diagnosis rate of the disease in Latin America and Africa are likely to restrain the NCC therapeutics market in Latin America and Middle East & Africa during the forecast period.

Global NCC Therapeutics Market: Key Players

Major players operating in the global NCC therapeutics market are Amedra Pharmaceuticals LLC, GlaxoSmithKline, Bayer HealthCare Pharmaceuticals, Inc., Par Pharmaceutical, Novartis Pharmaceuticals Corporation, Allergan, Inc., and Hospira (parent organization: Prizer).

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Have query on this report?

Make an Enquiry

Success Stories

Our Clients